Direct Immunofluorescence, Tissue Biopsy (Cutaneous, Mucosal, Epithelial)
Ordering Recommendation
Use with serum immunobullous disease/epithelial antibody testing and separate formalin-fixed tissue histopathology for assessment of pruritic, urticarial, blistering, and/or erosive disorders. Use with separate formalin-fixed tissue histopathology for assessment of inflammatory, immune-mediated cutaneous disease.
Optimal specimen location and complementary serum testing and/or histopathology examination vary according to disease type. Note that specimen location and transport medium/fixative are different for direct immunofluorescence testing and fixed-tissue histopathology.
New York DOH Approval Status
Specimen Required
Tissue: skin, mucosa (oral, conjunctival, genital, esophageal), other epithelium (gastrointestinal, respiratory, urinary).
Transport tissue (optimal 4-6 mm) in Michel's medium (ARUP supply #45462) available online through eSupply using ARUP ConnectTM or call ARUP Client Services at 800-522-2787. Also acceptable: Zeus tissue fixative. Label container with transport medium type, if not an ARUP-supplied vial.
Room temperature. Also acceptable: Refrigerated.
Formalin-fixed tissue. Frozen in Michels medium. Solid organs or solid organ tissue. Tissue in container of unknown or unacceptable transport medium. Tissue sections on slides, prestained or unstained.
Ambient: 10 days; Refrigerated: 10 days; Frozen: Unacceptable
Methodology
Direct Immunofluorescence
Performed
Varies
Reported
3-9 days
Reference Interval
By report
Interpretive Data
Refer to report
Performed by non-ARUP Laboratory
Note
Hotline History
Hotline History
CPT Codes
88346; 88350 x5
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0092571 | Cutaneous Direct IF, Biopsy | 6471-7 |
2010916 | EER Cutaneous Direct IF, Biopsy |
Aliases
- atypical epithelial antibody-associated disease
basement membrane zone antibody-associated disease
Brunsting-Perry cicatricial pemphigoid
Brunsting-Perry pemphigoid
bullous disease
bullous disease of childhood
bullous lupus erythematosus
bullous pemphigoid
bullous systemic lupus erythematosus
celiac rash
cell surface antibody-associated disease
childhood immunobullous disease
chronic bullous disease
chronic bullous disease of childhood
cicatricial pemphigoid
Cutaneous Direct Immunofluorescence, Biopsy
cutaneous herpetiformis
cutaneous lupus
dermal basement membrane zone (floor) antibodies with split skin substrate
dermatitis herpetiformis
DIF
drug hypersensitivity
drug reaction
endemic pemphigus
epidermolysis bullosa acquisita
epithelial antibody-associated disease
epithelial basement membrane zone antibody-associated disease
epithelial cell surface antibody associated disease
fogo selvagem
gluten rash
Henoch-Schönlein purpura
herpetiformis
hypocomplementemic urticarial vasculitis
ICS antibodies
IgA mucous membrane pemphigoid
IgA pemphigus
IgA variant epidermolysis bullosa acquisita (EBA)
IgA vasculitis
IgG/IgA basement membrane zone antibodies
IgG pemphigus variant
IgG variant pemphigus
immune-mediated vasculitis
immunobullous disease of childhood
intercellular IgG/IgA dermatosis
intercellular substance antibodies
intraepidermal neutrophilic IgA dermatosis
leukocytoclastic vasculitis
lichen planus
lichenoid reaction
linear IgA bullous dermatosis
Linear IgA Bullous, Tissue
linear IgA disease
linear IgG/IgA bullous dermatosis
lupus
lupus erythematosus
Lupus Erythematous, Tissue
mixed epithelial antibody-associated disease
mixed immunobullous disease of childhood
mucous membrane pemphigoid
ocular cicatricial pemphigoid
pemphigoid gestationis
pemphigoid, tissue
pemphigoid variants
Pemphigus
pemphigus erythematosus
pemphigus foliaceus
pemphigus variant
pemphigus vegetans
pemphigus vulgaris
pemphigus, tissue
porphyria and pseudoporphyria, tissue
porphyria, pseudoporphyria tissue
skin immunofluorescence
subacute cutaneous lupus erythematosus
subcorneal pustular dermatosis
subepithelial immunobullous disease
urticaria
urticarial pemphigoid
urticarial vasculitis
vasculitis
vasculopathy